ZA971663B - Porcine reproductive and respiratory syndrome vaccine. - Google Patents

Porcine reproductive and respiratory syndrome vaccine.

Info

Publication number
ZA971663B
ZA971663B ZA9701663A ZA971663A ZA971663B ZA 971663 B ZA971663 B ZA 971663B ZA 9701663 A ZA9701663 A ZA 9701663A ZA 971663 A ZA971663 A ZA 971663A ZA 971663 B ZA971663 B ZA 971663B
Authority
ZA
South Africa
Prior art keywords
respiratory syndrome
porcine reproductive
syndrome vaccine
vaccine
porcine
Prior art date
Application number
ZA9701663A
Inventor
Richard A Hesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA971663(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA971663B publication Critical patent/ZA971663B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
ZA9701663A 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine. ZA971663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01

Publications (1)

Publication Number Publication Date
ZA971663B true ZA971663B (en) 1997-08-26

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701663A ZA971663B (en) 1996-03-01 1997-02-26 Porcine reproductive and respiratory syndrome vaccine.

Country Status (19)

Country Link
EP (1) EP0894007A1 (en)
JP (1) JP3135069B2 (en)
KR (1) KR100297537B1 (en)
CN (1) CN1165342C (en)
AR (1) AR006023A1 (en)
AU (1) AU2277497A (en)
BG (1) BG64693B1 (en)
BR (1) BR9708443B1 (en)
CA (1) CA2248182C (en)
CO (1) CO4600644A1 (en)
CZ (1) CZ273798A3 (en)
EE (1) EE04741B1 (en)
HU (1) HUP9901958A3 (en)
MY (1) MY115070A (en)
PL (1) PL328627A1 (en)
RU (1) RU2187333C2 (en)
SK (1) SK119498A3 (en)
WO (1) WO1997031651A1 (en)
ZA (1) ZA971663B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
CA2290220C (en) 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
JP3961222B2 (en) 1999-03-08 2007-08-22 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー PRRSV vaccine
CA2370372C (en) 1999-04-22 2009-02-24 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
TW200604526A (en) 2004-06-18 2006-02-01 Unviersity Of Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
ES2603553T3 (en) 2005-06-24 2017-02-28 Regents Of The University Of Minnesota PRRS viruses, infectious clones, mutants thereof, and methods of use
RU2354333C1 (en) * 2007-07-24 2009-05-10 ФГОУ ВПО Омский государственный аграрный университет Method for early diagnostics of postnatal diseases in sows
CN101612395B (en) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 Method for producing blue-ear disease vaccine by culturing sensitive cell
AR078253A1 (en) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed METHODS TO REDUCE ANTIVIRICAL ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH BETTER IMMUNOGENICITY
EP2675476B1 (en) 2011-02-17 2015-09-16 Boehringer Ingelheim Vetmedica GmbH Commercial scale process for production of prrsv
UA117272C2 (en) 2011-02-17 2018-07-10 Бьорінгер Інгельхайм Ветмедіка Гмбх NEW EUROPEAN PRRSV STRAIN
WO2013017568A1 (en) 2011-07-29 2013-02-07 Boehringer Ingelheim Vetmedica Gmbh INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
KR101300528B1 (en) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 Composition for prevention and treatment of Actinobacillus pleuropneumoniae infection
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EP4012025A1 (en) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Transport medium for samples containing nucleic acids and/or proteins
CZ309704B6 (en) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transport medium for virus transport and storage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
WO1993007898A1 (en) * 1991-10-14 1993-04-29 Akzo Nobel N.V. Porcine reproductive respiratory syndrome vaccine and diagnostic
FR2686097B1 (en) * 1992-01-14 1994-12-30 Rhone Merieux PREPARATION OF ANTIGENS AND MYSTERY DISEASE VIRUS VACCINES, ANTIGENS AND VACCINES OBTAINED FOR THE PREVENTION OF THIS DISEASE.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
DK0683816T3 (en) * 1993-02-08 2001-01-08 Bayer Ag Method for Cultivating Porcine Reproduction and Respiratory Disease Virus and Its Use in Vaccines
ES2074950B1 (en) 1993-09-17 1996-03-16 Iberica Cyanamid VACCINE FOR THE PREVENTION OF REPRODUCTIVE AND RESPIRATORY DISEASE OF THE SOW.
DE69522984T2 (en) * 1994-04-11 2002-04-25 Akzo Nobel Nv Pig reproductive respiratory syndrome virus vaccine European strains
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
SK119498A3 (en) 1999-07-12
EE9800267A (en) 1999-02-15
BR9708443B1 (en) 2012-06-12
HUP9901958A3 (en) 2000-04-28
WO1997031651A1 (en) 1997-09-04
KR19990087432A (en) 1999-12-27
RU2187333C2 (en) 2002-08-20
BG64693B1 (en) 2005-12-30
PL328627A1 (en) 1999-02-15
EE04741B1 (en) 2006-12-15
BG102809A (en) 1999-05-31
AR006023A1 (en) 1999-07-21
CA2248182A1 (en) 1997-09-04
CO4600644A1 (en) 1998-05-08
JPH11506122A (en) 1999-06-02
JP3135069B2 (en) 2001-02-13
EP0894007A1 (en) 1999-02-03
KR100297537B1 (en) 2001-10-26
CN1165342C (en) 2004-09-08
HUP9901958A2 (en) 1999-10-28
CZ273798A3 (en) 1999-02-17
CA2248182C (en) 2004-04-20
MX9807083A (en) 1998-12-31
AU2277497A (en) 1997-09-16
CN1216922A (en) 1999-05-19
BR9708443A (en) 1999-08-03
MY115070A (en) 2003-03-31

Similar Documents

Publication Publication Date Title
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
GB9418775D0 (en) Vaccine for the preventoin of porcine reproductive and respiratory syndrome
AU3699197A (en) Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
EP0632099A3 (en) Organopolysiloxane and method for the preparation thereof.
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
EP0642802A3 (en) Inhalation device.
HUP9801570A3 (en) Polysiloxane-comprising perfluoroalkyl ethers, and the preparation and use thereof
EP0655256A3 (en) Inhaler.
ZA975889B (en) HIV envelope polypeptides and vaccine.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
MXPA00004635A (en) Inhalation device.
ZA987092B (en) Inhalation device.
ZA982021B (en) Inhalation device.
ZA966776B (en) Device in inhalers.
ZA982019B (en) Inhalation device.
AU133903S (en) Inhaler device
GB9620795D0 (en) Vaccines
HU9602421D0 (en) Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
EP0958373A4 (en) Vaccines
EP0677787A3 (en) Mask and mask supporting mechanism.
ZA9711047B (en) Formulation and use.
GB9618890D0 (en) An immunogenic determinant
HK1016071A (en) Porcine reproductive and respiratory syndrome vaccine
ZA9610510B (en) Novel peptides, the preparation and use thereof.
EP0759778A4 (en) Non-infective vaccines